Skip to content
by Legal Desire
28 July 2026

Latham Advises on Scribe Therapeutics’ US$155.51 Million IPO

Advising firms

Deal team

16 lawyers named
LawyerFirmSeniorityPracticeOffice
Shayne Kennedy Lead Latham & Watkins LLP Partner Capital Markets Orange County
Ross McAloon Lead Latham & Watkins LLP Partner Capital Markets Orange County
Greg Van Buiten Latham & Watkins LLP Associate Capital Markets Not stated
Kennedy Holmes Latham & Watkins LLP Associate Capital Markets Not stated
Austin Urbach Latham & Watkins LLP Associate Capital Markets Not stated
Robert Yeh Latham & Watkins LLP Counsel intellectual property San Diego
Patrick Chew Latham & Watkins LLP Associate intellectual property Not stated
Heather Deixler Latham & Watkins LLP Partner data privacy and cybersecurity Bay Area
Oliver Mobasser Latham & Watkins LLP Counsel data privacy and cybersecurity London
Betty Pang Latham & Watkins LLP Partner healthcare Bay Area
Chad Jennings Latham & Watkins LLP Counsel FDA Washington, D.C.
Michelle Carpenter Latham & Watkins LLP Partner executive compensation and employee benefits Los Angeles
Sara Schlau Latham & Watkins LLP Counsel executive compensation and employee benefits Orange County
Genie Yae Latham & Watkins LLP Associate executive compensation and employee benefits Not stated
Eric Cho Latham & Watkins LLP Partner tax Los Angeles
Joe Marcus Latham & Watkins LLP Associate tax Not stated

13 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 156m (US$155.51 Million)
What the figure measures
Issue size
Client
Scribe Therapeutics Inc.Issuer
Counterparties
underwriters (Underwriters)